Insights

Scale opportunity Global reach and large headcount indicate potential for enterprise-wide contracts across trials, analytics, and healthcare intelligence services. Focus on multi-country trial management, data analytics platforms, and privacy-compliant data solutions to address wide-ranging customer needs.

Data power IQVIA leverages Healthcare-grade AI and high-quality health data for insights, creating opportunities to upsell advanced analytics, real-world evidence, and AI-driven trial optimization to pharma, biotech, and medical device customers.

Growth momentum Positive Q2 signals and raised full-year outlook suggest expanding demand for R&D solutions, data services, and software products. Target clients seeking scalable, integrated platforms for trial operations and revenue-cycle intelligence.

Privacy leadership Strong emphasis on patient privacy and privacy-enhancing technologies can be a differentiator when selling compliant data solutions, risk management services, and regulated data sharing for pharmaceutical and government buyers.

Cross-sell potential Diverse service portfolio spanning clinical research, commercial insights, and healthcare intelligence enables cross-sell opportunities to existing life sciences customers, including pharma, biotech, medical devices, and payers seeking end-to-end solutions.

IQVIA Tech Stack

IQVIA uses 8 technology products and services including Palantir, Figma, Microsoft Outlook, and more. Explore IQVIA's tech stack below.

  • Palantir
    Advanced Analytics And Data Science
  • Figma
    Design
  • Microsoft Outlook
    Email
  • Jamf Pro
    Endpoint Protection
  • Oracle ERP Cloud
    Enterprise Resource Planning
  • dunnhumby
    Retail Operations Software
  • Futuri
    Social Media Marketing Software
  • Webex
    Web Conferencing

Media & News

IQVIA's Email Address Formats

IQVIA uses at least 2 format(s):
IQVIA Email FormatsExamplePercentage
First.Last@iqvia.comJohn.Doe@iqvia.com
95%
F_Last@iqvia.comJ_Doe@iqvia.com
2%
FLast@iqvia.comJDoe@iqvia.com
2%
First.Middle@iqvia.comJohn.Michael@iqvia.com
1%
First.Last@quintiles.comJohn.Doe@quintiles.com
98%
FLast@quintiles.comJDoe@quintiles.com
1%
First.Middle@quintiles.comJohn.Michael@quintiles.com
1%

Frequently Asked Questions

What is IQVIA's phone number?

Minus sign iconPlus sign icon
You can contact IQVIA's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is IQVIA's stock symbol?

Minus sign iconPlus sign icon
IQVIA is a publicly traded company; the company's stock symbol is IQV.

What is IQVIA's official website and social media links?

Minus sign iconPlus sign icon
IQVIA's official website is iqvia.com and has social profiles on LinkedInCrunchbase.

How much revenue does IQVIA generate?

Minus sign iconPlus sign icon
As of July 2026, IQVIA's annual revenue is estimated to be $16B.

What is IQVIA's SIC code NAICS code?

Minus sign iconPlus sign icon
IQVIA's SIC code is 2835 - In Vitro and In Vivo Diagnostic Substances NAICS code is 62 - Health Care and Social Assistance.

How many employees does IQVIA have currently?

Minus sign iconPlus sign icon
As of July 2026, IQVIA has approximately 81K employees across 6 continents, including North AmericaAsiaEurope. Key team members include Cfo, Amesa: M. W.Cfo - Middle East: A. A. W.Cfo & Director - South Asia: A. B.. Explore IQVIA's employee directory with LeadIQ.

What industry does IQVIA belong to?

Minus sign iconPlus sign icon
IQVIA operates in the Hospitals and Health Care industry.

What technology does IQVIA use?

Minus sign iconPlus sign icon
IQVIA's tech stack includes PalantirFigmaMicrosoft OutlookJamf ProOracle ERP ClouddunnhumbyFuturiWebex.

What is IQVIA's email format?

Minus sign iconPlus sign icon
IQVIA's email format typically follows the pattern of First.Last@iqvia.com. Find more IQVIA email formats with LeadIQ.

How much funding has IQVIA raised to date?

Minus sign iconPlus sign icon
As of July 2026, IQVIA has raised $4.6B in funding. The last funding round occurred on Jun 04, 2026 for $2B.
IQVIA logo

IQVIA

Hospitals and Health CareNorth Carolina, United States10001+ Employees

IQVIA is a global provider in the hospitals and health care sector offering clinical research services, commercial insights, and healthcare intelligence to life sciences and healthcare organizations. Its suite of solutions is powered by IQVIA Connected Intelligence, leveraging health data, healthcare-grade AI, advanced analytics, and current technologies to deliver actionable insights. The company operates in more than 100 countries and has a substantial global workforce, with its listed location at 2400 Ellis Road, Durham, North Carolina, United States. IQVIA is described as a global leader in protecting individual patient privacy, employing privacy-enhancing technologies to support analysis at scale while safeguarding privacy. IQVIA is publicly traded on the New York Stock Exchange under the ticker IQV, and has pursued partnerships and collaborations to translate data-driven insights into healthcare activation.

Section iconCompany Overview

Phone number
Website
iqvia.com
SIC Code
2835 - In Vitro and In Vivo Diagnostic Substances
Stock Symbol
IQV
NAICS Code
62 - Health Care and Social Assistance
Employees
10001+

Section iconFunding & Financials

  • $4.6B

    IQVIA has raised a total of $4.6B of funding over 5 rounds. Their latest funding round was raised on Jun 04, 2026 in the amount of $2Bas a post_ipo_debt.

  • $10B

    IQVIA's revenue is estimated to be in the range of $10B

Section iconFunding & Financials

  • $4.6B

    IQVIA has raised a total of $4.6B of funding over 5 rounds. Their latest funding round was raised on Jun 04, 2026 in the amount of $2Bas a post_ipo_debt.

  • $10B

    IQVIA's revenue is estimated to be in the range of $10B

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.